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Background: A few and partial data are available on psychosocial morbidity among cancer patients in Mediterranean countries.
As a part of a more general investigation (Southern European Psycho-Oncology Study—SEPOS), the rate of psychosocial
morbidity and its correlation with clinical and cultural variables were examined in cancer patients in Italy, Portugal and Spain.
Methods: A convenience sample of cancer outpatients with good performance status and no cognitive impairment were
approached. The Hospital Anxiety–Depression scale (HAD-S), the Mini-Mental Adjustment to Cancer scale (Mini-MAC), and
the Cancer Worries Inventory (CWI) were used to measure psychological morbidity, coping strategies and concerns about
illness.
Results: Of 277 patients, 34% had pathological scores (bborderline casesQ plus btrue casesQ) on HAD-S Anxiety and 24.9% on
HAD-S Depression. Total psychiatric bcasenessQ was 28.5% and 16.6%, according to different HAD cut-offs (14 and 19,
respectively). Significant relationships of HAD-S Anxiety, HAD-S Depression, HAD-S Total score, with Mini-MAC Hopeless
and Anxious Preoccupation, and CWI score were found. No differences emerged between countries on psychosocial morbidity,
while some differences emerged between the countries on coping mechanisms. Furthermore, Fatalism, Avoidance and
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Conclusions: One-third of the patients presented anxiety and depressive morbidity, with significant differences in characteristics
of coping in Mediterranean countries in comparison with English-speaking countries.
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Several studies have shown that 40% to 50% of
cancer patients report psychiatric disorders, especially
depression (Sellick and Crooks, 1999). Increased
length of stay in the hospital (Prieto et al., 2002),
maladaptive coping (Watson et al., 1991), poor quality
of life (Grassi et al., 1996), poor response to chemo-
therapy (Walker et al., 1999), risk of suicide (Hen-
rikkson et al., 1995), and risk of recurrence of cancer
(Watson et al., 1999) have been related to psychoso-
cial morbidity.
While cultural issues have been indicated as
important variables to be considered when evaluating
psychosocial aspects of cancer (Chambers, 2000;
Holland, 2004), a few data are available in the
Mediterranean area, where problems in doctor–patient
communication and paternalistic attitudes represent
major obstacles in eliciting psychosocial problems
secondary to cancer (Arraras et al., 1995; Mystadikou
et al., 1996; Grassi et al., 2000).
In order to extend the knowledge on this topic, the
Southern European Psycho-Oncology Study (SEPOS)
was set up. The aims were: (i) to examine the rate of
psychosocial morbidity and related variables in cancer
patients; (ii) to rate the ability of oncologists to detect
their patientsT psychosocial morbidity; and (iii) to
develop and apply a training model to improve
doctors’ skills in recognizing psychological disorders.
In the present study, findings relative to the first aim
are reported.2 Data from Switzerland are still in progress and are not
reported here.2. Methods
The study was conducted in three countries of the
European Union, namely Italy (Hospital S. Anna,
Ferrara), Spain (Hospital Duran i Reynals, Barcelona)
and Portugal (Hospital S. Jose´, Lisbon), and in a non-EU country (Switzerland, Lugano Hospital)2. A
convenience sample of cancer outpatients meeting
the following criteria was recruited: an age between
18 and 70 years; a diagnosis of cancer between 6 and
18 months; a Karnofosky Performance Status scale
z80 (Karnofsky and Burchenal, 1949); and no
cognitive deficits due to disease or treatment. The
study was approved by the ethical committee or
related boards of the hospitals and each patient gave
his/her written consent to participate.
The Hospital Anxiety–Depression scale (HAD-S)
(Zigmond and Snaith, 1983) was used to assess
anxiety and depression. According to Carroll et al.,
1993, scores between 8 and 10 on Anxiety and
Depression subscales indicate bborderlineQ cases,
while scores z11 identify bclinicalQ bcasesQ. The
cut-off scores of 14 and 19 on the HAD-S Total were
used to evaluate blikely psychiatric casenessQ (Ibbot-
son et al., 1994) and bcasenessQ (Razavi et al., 1990),
respectively.
The Mini-Mental Adjustment to Cancer scale
(Mini-MAC) (Watson et al., 1994) was used to
assess coping to cancer, namely Hopeless, Fighting
Spirit, Anxious Preoccupation, Fatalism, and Avoid-
ance. Provisional cut-off scores on Anxious Preoc-
cupation and Hopeless (mean scoreF1 SD) were
used to assess maladaptive coping (Watson et al.,
1989).
A modified version of the Cancer Worries Inven-
tory (CWI) (D’Errico et al., 1999) was used to rate the
main preoccupations caused by cancer (e.g. physical
and emotional problems, relational worries).
Student’s t-test, ANOVA, Pearson’s r correlation
test, and chi-square test were used when appropriate.
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Of 287 patients participating, data were available
for 277 (Italy, n=119; Portugal, n=90, Spain, n=68).
The patients’ socio-demographic and clinical charac-
teristics are reported in Table 1. Portuguese patients
were the oldest (60.06F11.16 years) and Spanish the
youngest (53.82F15.55 years) ( F=4.9, df ,2,
p=0.008). There was a higher prevalence of males
in the Spanish (57.4%) than in the Portuguese group
(10%) (v2=44.96, df,2, p=0.001). Education was
higher among Spanish (mean 11.88F6.37 years) and
lower among Portuguese patients (5.09F3.18 years)Table 1
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Local disease 133 (48%)
Loco-regional 95 (34.3%)
Metastatic 49 (17.7%)(F=39.5, df.2, p=0.001). Significant differences were
also reported on stage of illness, with the highest
prevalence of metastatic patients in Italy (32.7%) and
the lowest in Portugal (3.8%) (v2=30.96, df,4,
p=0.001).
3.1. Psychosocial morbidity and maladaptive coping
Forty-seven subjects (17%) proved to be bclinical
casesQ on HAD-S Anxiety and 25 (9%) on HAD-S
Depression (cut-off score=11). A further group of
patients were bborderline casesQ (HAD-S score 8–10),
specifically 47 (17%) on HAD-S Anxiety and 44
(15.9%) on HAD-S Depression, yielding a total of 94
patients (34%) with anxiety and 69 (24.9%) with
depression. On the HAD-S Total, 79 subjects (28.5%)
were blikely psychiatric casesQ (cut-off=14), and 46
(16.6%) were bcasesQ (cut-off=19).
Maladaptive coping was found in 94/277
patients (33.93%), with 58 (20.94%) reporting high
scores on Anxious Preoccupation and 36 (13%) on
Hopeless.
Significant correlations were found between HAD-
S and both CWI Total and Mini-MAC Hopeless and
Anxious Preoccupation (see Table 2 for details).
3.2. Correlation with other variables
Females reported higher scores on the Mini-MAC
Anxious Preoccupation (16.96F5.41 vs. 19.23F5.23,
t=3.2, p=0.002) and Fatalism (14.34F2.72 vs.
15.56F3.1, t=3.03, p=0.003) than males. No differ-
ence was found on any psychological measure
according to stage and treatment. Breast cancer
patients (n=141, 50.9%) did not differ from the group
of patients affected by other cancers (n=136, 49.1%)
on HAD-S bcasenessQ.
A similar prevalence was found between the three
centres on borderline and clinical anxiety (v2=6.71,
df,4, p=0.15), borderline and clinical depression
(v2=7.08, df,4, p=0.13), and total bcasenessQ (HAD-
SN14, v2=0.66, df,2, p=0.99; HAD-SN19, v2=0.88,
df,2, p=0.64). Italian patients reported marginally
higher scores on HAD-S Depression (F=3.63, df,2,
p=0.028) and marginally lower scores on HAD-S
Anxiety (F=3.73, df,2, p=0.025). Portuguese patients
reported higher scores on the Mini-MAC Fighting
Spirit (F=4.55, df,2, p=0.01), Fatalism (F=26.01,
Table 2


















HAD-S total 0.89** 0.88**
FS 0.06 0.34* 0.22*
H 0.51** 0.54** 0.59** 0.28*
F 0.01 0.09 0.06 0.41** 0.01
AP 0.61** 0.45** 0.60 0.01 0.54** 0.15
Av 0.11 0.07 0.02 0.28* 0.04 0.35* 0.21
CWI 0.61** 0.50** 0.63 0.12 0.53** 0.01 0.57** 0.05
* p=0.01.
** p=0.001.
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(Table 3).
Incomparisonwith theEnglishnormativedataon the
Mini-MAC (Watson, personal communication), higher
scores on Fatalism (15.25F3.05 vs. 13.76F2.91,
t=6.86, p=0.001), Avoidance (12.04F3.35 vs.
9.49F2.5, t=12.29, p=0.001), and, marginally, Hope-
less (12.63F5.03 vs. 11.96F3.91, t=2.11, p=0.036)
were found in our study.4. Discussion
This is the first investigation comparing psycho-
social data among cancer patients in the Mediterra-
nean area.
Approximately one third of the patients were
bcasesQ or blikely casesQ, as far as anxiety and
depression are concerned. These data are similar toTable 3
Mean (and standard deviation) for the single psychological measures in t
Measures Total (n=277) Italy (n=119)
HAD-S
Anxiety 6.48 (4.27) 5.57 (3.86)
Depression 4.62 (4.11) 5.41 (4.50)
Total score 11.1 (7.41) 10.99 (7.66)
Mini-MAC
Fighting Spirit 12.62 (2.21) 12.19 (2.30)
Hopeless 12.63 (5.03) 13.24 (5.76)
Fatalism 15.25 (3.05) 14.59 (3.01)
Anxious Preoccupation 18.65 (5.81) 18.93 (6.48)
Avoidance 12.04 (3.35) 11.39 (3.72)
Cancer Worries Inventory 13.49 (10.65) 12.43 (10.13)what reported by Moorey et al. (1991) who found a
27% prevalence of HAD-S anxiety and a 20.1%
prevalence of depression, while Carroll et al. (1993)
pointed out a prevalence of 42% and 8.1%, respec-
tively. In line with Razavi et al.’s (1990) study,
bcasenessQ (HAD-S Total) ranged between 16%
(probable major psychiatric disorder) and 28% (gen-
eral psychiatric bcasenessQ). Taken together, our data
confirm that psychosocial morbidity is a significant
clinical problem in Southern European cancer
patients.
A second result was that hopelessness and anxious
preoccupation were the most significant coping styles
associated with psychosocial morbidity. This is in
agreement with data showing that both pessimistic
responses and extreme focusing on illness are
indicators of maladjustment to cancer (Watson et al.,
1991). In contrast with previous research (Greer et al.,
1990), the role of fighting spirit was not significant inhe total sample and according to country
Portugal (n=90) Spain (n=68) F p
7.21 (4.35) 6.86 (4.59) 3.63 ns
4.10 (3.66) 4.07 (3.95) 3.73 ns
11.35 (7.26) 10.94 (7.46) 0.1 ns
13.10 (2.24) 12.71 (1.86) 4.55 0.01
12.04 (4.06) 12.35 (4.79) 1.60 ns
16.95 (2.68) 14.05 (2.59) 26.01 0.001
19.18 (5.54) 17.38 (4.65) 2.16 ns
13.00 (2.87) 11.89 (2.97) 6.24 0.002
14.28 (11.55) 14.19 (10.25) 0.98 ns
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that hopelessness, rather than fighting spirit, was a key
factor in influencing cancer patients’ quality of life
and possibly survival (Watson et al., 1999). Further-
more, hopelessness and anxious preoccupation were
found to be the only factors improving after anti-
depressant treatment among breast cancer patients
(Grassi et al., 2004).
As expected, psychosocial morbidity was associated
with the extent of concerns about illness. This confirms
the relationship of worries with psychological malad-
justment (Spencer et al., 1999; Mathews et al., 2002)
and underscores the need for an early and routine
assessment of the impact of cancer on the patients and
their emotional response (Maguire et al., 1996).
Regarding the role of cultural factors, minor
differences were found between the participating
centres on psychosocial morbidity (i.e. anxiety,
depression, and bcasenessQ) and cancer-related wor-
ries. More data are necessary to interpret the differ-
ences in coping (Mini-MAC) between Portuguese
patients, on the one hand, and Italian and Spanish, on
the other. Education, gender and age can be possible
explanatory factors, as well as more specific cultural
variables which need to be studied in more detail.
Likewise, further research is necessary to understand
the differences (higher fatalism, avoidance and hope-
lessness) between Southern and Northern European
patients.
Important limitations should be mentioned. First,
psychosocial morbidity was not evaluated by using a
structured clinical interview, which could have given
more detailed data. Second, the small size of the
sample and the good performance status prevent us
from generalizing the results to patients in an
advanced phase of illness and poorer performance
status. Third, even if the sample was representative of
the centres and the regions where the study was
carried out, we cannot generalize the results to the
whole cancer population of the three countries.
Fourth, most patients were females with a diagnosis
of early breast cancer and this does not allow us to
understand the role of gender and medical variables
on psychosocial morbidity in this specific cultural
setting. Lastly, variables related to religious beliefs,
namely the Catholic tradition in Mediterranean
countries, were not taken into consideration and
should be explored in future studies.To conclude, at least one third of Southern Euro-
pean cancer patients presented clinical anxiety and
depression, which were associated with maladaptive
coping and worries about their disease. The cultural
aspects of this geographical area should be the focus
of further studies both in educational and clinical
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